News from the healthcare data industry
Tom Andriola explains The Collaboratories @ UCI™ and how UCI is putting data to work to strengthen its commitment to the mission December 1, 2021“The adage, ‘data is the new oil’ is outdated,” according to Tom Andriola, UCI’s vice chancellor for information, technology & data and chief data officer. “Rather, we should…
James Kugler, Chief Digital Officer, Merck KGaA Darmstadt; CEO of EMD Digital; and Board Member of Syntropy explores how we enable collaboration within and between institutions in a secure and ethical way when the institution and practice of science are up for debate. About Syntropy Syntropy is a technology company…
When it comes to unlocking the value of healthcare data, the issue is not the amount of data available; it is how it’s collected, curated and analyzed that determines its full value. Although healthcare data is growing rapidly at 48% YoY, according to an annual study from IDC, the percentage of…
November 25, 2021 Ieso has raised $53 million in second-round financing that will be used to bring its digital therapeutics (DTx) through to market in its home market of the UK, as well as the US. The company’s artificial intelligence-powered software uses cognitive behavioural therapy techniques to help patients suffering…
COLUMBIA, Md. & DENVER–(BUSINESS WIRE)–BigBear.ai, a leading provider of artificial intelligence, machine learning, big data analytics, and cyber solutions, and Palantir Technologies Inc. (NYSE: PLTR), a software company that builds enterprise data platforms for use by organizations with complex and sensitive data environments, today announced that they have entered into a…
CAMBRIDGE, Mass., Nov. 30, 2021 /PRNewswire/ — nference, the AI-driven health technology company, today announced publication of a preprint study in bioRxiv that found the genetic alteration of some linear peptides expressed specifically in the human heart are mimicked by the SARS-CoV-2 polyprotein (replicase). The study has been submitted for peer-review. Authors of “Genetic alteration…
Dr. Fleming brings decades of experience and leadership transforming operational performance across healthcare and Life Sciences San Francisco – November 30, 2021: Komodo Health, a leader in software-driven health analytics, today announced the appointment of Edd Fleming, MD, to its board of directors, further catalyzing the company’s role as the foundational…
30-11-2021 The US Food and Drug Administration (FDA) has issued a draft guidance for drugmakers relating to the use of real-world evidence (RWE). In the guidance, titled Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products, advice is provided for companies either designing a registry or proposing…
Collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum are intended expand access to the latest and most advanced technologies for cancer care Chicago, Nov 30 2021 — GE Healthcare announced collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum as part of its vision to advance care,…
DURHAM, N.C., Nov. 30, 2021 /PRNewswire/ — Target RWE, a leading real-world evidence (RWE) solutions company for the healthcare industry, today announced that Derek Evans, MBA, has joined the company as President. “In this new role, Derek will lead all operating functions as we continue to leverage our significant software, data, and intellectual…